Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 1,530,000 shares, a drop of 56.0% from the December 31st total of 3,480,000 shares. Currently, 4.2% of the company’s shares are short sold. Based on an average daily volume of 6,330,000 shares, the short-interest ratio is presently 0.2 days.

Cardio Diagnostics Stock Down 6.5 %

Shares of NASDAQ:CDIO traded down $0.03 on Wednesday, hitting $0.45. 616,592 shares of the company’s stock were exchanged, compared to its average volume of 4,236,430. Cardio Diagnostics has a 12 month low of $0.19 and a 12 month high of $2.40. The business’s 50 day simple moving average is $0.70 and its two-hundred day simple moving average is $0.46.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.